At the molecular level, it has been described how, unlike the breast, which has a predominant presence of ERα, which promotes DNA transcription, there is a greater presence of ERβ in the skin, which inhibits this expression and significantly reduces tumor capacity [20]. Here, ESR2 is linked to neoplasm.